Trials / Completed
CompletedNCT07500155
Postmarket Study of Tarvos Microguidewire in Neurovascular Interventional Surgery
Evaluation of Clinical Effectiveness and Safety of Tarvos Microguidewire in Neurovascular Interventional Surgery
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 121 (actual)
- Sponsor
- Keuro MedTech · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This investigation is to evaluate the clinical effectiveness and safety of the Tarvos Microguidewire in the neurovascular interventional surgery. It is a retrospective multicenter medical device clinical study with real-world data.
Conditions
- Intracranial Aneurysm
- AVM - Cerebral Arteriovenous Malformation
- AV Fistula
- Acute Ischemic Stroke
- Extracranial Atherosclerosis
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Tarvos Microguidewire | This product is indicated for use in neurovascular interventions to assist in the delivery of diagnostic or therapeutic devices to the target lesion site. |
Timeline
- Start date
- 2026-01-29
- Primary completion
- 2026-03-15
- Completion
- 2026-03-15
- First posted
- 2026-03-30
- Last updated
- 2026-04-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07500155. Inclusion in this directory is not an endorsement.